Sumitomo Mitsui Trust Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-11,738
Closed -$724K 1195
2021
Q1
$724K Sell
11,738
-1,142
-9% -$72.3K ﹤0.01% 1052
2020
Q4
$840K Buy
12,880
+953
+8% +$54.8K ﹤0.01% 1011
2020
Q3
$591K Hold
11,927
﹤0.01% 1020
2020
Q2
$569K Buy
11,927
+343
+3% +$16.5K ﹤0.01% 1012
2020
Q1
$493K Buy
+11,584
New +$572K ﹤0.01% 1001

Other funds holding GMED

Sumitomo Mitsui Trust Group's GMED Position: Q2 2021 in Review

Sumitomo Mitsui Trust Group sold out of Globus Medical (GMED) in Q2 2021, closing a stake of 11,738 shares — an estimated $724K sold.

Sumitomo Mitsui Trust Group first reported a position in GMED in Q1 2020 and held it in 5 quarters. The position peaked at $840K in Q4 2020. 354 funds tracked by Wall St. Rank hold GMED as of Q2 2021.

  • Sumitomo Mitsui Trust Group reported no remaining Globus Medical position as of Q2 2021 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 11,738 Globus Medical shares in Q2 2021, an estimated $724K.
  • Sumitomo Mitsui Trust Group first reported a position in Globus Medical in Q1 2020 and held it in 5 quarters.
  • Sumitomo Mitsui Trust Group's Globus Medical position peaked at $840K in Q4 2020.
  • 354 funds tracked by Wall St. Rank held Globus Medical as of Q2 2021.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2021, filed 2 Aug 2021.